Plasma lactate levels increase during hyperinsulinemic euglycemic clamp and oral glucose tolerance test

Journal of Diabetes Research

Volumn 2015, Issue , 2015, Pages

  Berhane, Feven ^a   Fite, Alemu ^a   Daboul, Nour ^a   Al Janabi, Wissam ^a   Msallaty, Zaher ^a   Caruso, Michael ^a   Lewis, Monique K ^a   Yi, Zhengping ^a   Diamond, Michael P ^b   Abou Samra, Abdul Badi ^c   Seyoum, Berhane ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AUGUSTA UNIVERSITY   (United States)

^c HAMAD MEDICAL CORPORATION   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLYCEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LACTIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; INSULIN; LIPID;

ADULT; ARTICLE; BODY MASS; ENDOCRINE PANCREAS FUNCTION TEST; FEMALE; GLUCOSE TOLERANCE; GLYCEROL BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; HYPERINSULINEMIC EUGLYCEMIC CLAMP TEST; IMPAIRED GLUCOSE TOLERANCE; LACTATE BLOOD LEVEL; LIPID BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; BLOOD; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; OBESITY;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; GLYCEROL; HUMANS; INSULIN; INSULIN RESISTANCE; LACTIC ACID; LIPIDS; MALE; MIDDLE AGED; OBESITY;

EID: 84929359362     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2015/102054     Document Type: Article

References (17)

1. J. H. Warram, B. C. Martin, A. S. Krolewski, J. S. Soeldner, and C. R. Kahn, "Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents," Annals of InternalMedicine, vol. 113, no. 12, pp. 909-915, 1990.
2. R. N. Bergman, D. T. Finegood, and M. Ader, "Assessment of insulin sensitivity in vivo," Endocrine Reviews, vol. 6, no. 1, pp. 45-86, 1985.
3. R. A. DeFronzo and E. Ferrannini, "Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease," Diabetes Care, vol. 14, no. 3, pp. 173-194, 1991.
4. L.-O. Ohlson, B. Larsson, P. Bjorntorp et al., "Risk factors for Type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedishmen born in 1913," Diabetologia, vol. 31, no. 11, pp. 798-805, 1988.
5. S. O. Crawford, R. C. Hoogeveen, F. L. Brancati et al., "Association of blood lactate with type 2 diabetes: the atherosclerosis risk in communities carotid MRI study," International Journal of Epidemiology, vol. 39, no. 6, pp. 1647-1655, 2010.
6. R. A. DeFronzo, "Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009," Diabetologia, vol. 53, no. 7, pp. 1270-1287, 2010.
7. S. Del Prato, R. C. Bonadonna, E. Bonora et al., "Characterization of cellular defects of insulin action in type 2 (non-insulindependent) diabetes mellitus,"The Journal of Clinical Investigation, vol. 91, no. 2, pp. 484-494, 1993.
8. J.-A. Simoneau, S. R. Colberg, F. L. Thaete, and D. E. Kelley, "Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women," The FASEB Journal, vol. 9, no. 2, pp. 273-278, 1995.
9. R. A. DeFronzo, J. D. Tobin, and R. Andres, "Glucose clamp technique: a method for quantifying insulin secretion and resistance," The American journal of physiology, vol. 237, no. 3, pp. E214-E223, 1979.
10. M. DiGirolamo, F. D. Newby, and J. Lovejoy, "Lactate production in adipose tissue: a regulated function with extra-adipose implications," The FASEB Journal, vol. 6, no. 7, pp. 2405-2412, 1992.
11. A. Avogaro, G. Toffolo, M. Miola et al., "Intracellular lactateand pyruvate-interconversion rates are increased in muscle tissue of non-insulin-dependent diabetic individuals," Journal of Clinical Investigation, vol. 98, no. 1, pp. 108-115, 1996.
12. M. S. Sabatine, E. Liu, D. A.Morrow et al., "Metabolomic identification of novel biomarkers ofmyocardial ischemia," Circulation, vol. 112, no. 25, pp. 3868-3875, 2005.
13. K.-D. Gerbitz, K. Gempel, and D. Brdiczka, "Mitochondria and diabetes: genetic, biochemical, and clinical implications of the cellular energy circuit," Diabetes, vol. 45,no. 2, pp. 113-126, 1996.
14. B. B. Lowell and G. I. Shulman, "Mitochondrial dysfunction and type 2 diabetes," Science, vol. 307, no. 5708, pp. 384-387, 2005.
15. D. A. Robertson, B. M. Singh, R. M. Baddeley, andM. Nattrass, "Metabolic abnormalities in obese patients with impaired glucose tolerance," Diabetic Medicine, vol. 7, no. 1, pp. 45-49, 1990.
16. A. J. Krentz, B. M. Singh, and M. Nattrass, "Impaired glucose tolerance is characterized by multiple abnormalities in the regulation of intermediarymetabolism," DiabeticMedicine, vol. 8, no. 9, pp. 848-854, 1991.
17. D. A. Robertson, B. M. Singh, andM.Nattrass, "Effect of obesity on circulating intermediary metabolite concentrations in the absence of impaired glucose tolerance," International Journal of Obesity, vol. 15, no. 10, pp. 635-645, 1991.